Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

46 trials with published results (13%)

Research Maturity

183 completed trials (53% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.7%

23 terminated out of 344 trials

Success Rate

88.8%

+2.3% vs benchmark

Late-Stage Pipeline

21%

73 trials in Phase 3/4

Results Transparency

25%

46 of 183 completed with results

Key Signals

46 with results89% success23 terminated

Data Visualizations

Phase Distribution

236Total
Not Applicable (109)
Early P 1 (4)
P 1 (19)
P 2 (31)
P 3 (31)
P 4 (42)

Trial Status

Completed183
Unknown55
Recruiting31
Terminated23
Withdrawn20
Not Yet Recruiting14

Trial Success Rate

88.8%

Benchmark: 86.5%

Based on 183 completed trials

Clinical Trials (344)

Showing 20 of 20 trials
NCT06273098Not ApplicableWithdrawn

School-Based Bladder Health Intervention

NCT05319561Not ApplicableCompleted

Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team

NCT07555964Not ApplicableNot Yet Recruiting

Comparing Clean Intermittent Self-catheterization and Indwelling Catheterization for the Management of Urinary Retention Before BPH Surgery.

NCT07435844Not ApplicableRecruiting

Effect of Comprehensive Spa Care on Kidney and Urological Conditions: A Clinical Study in Adult Patients

NCT07371429Phase 1Not Yet RecruitingPrimary

A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis Antibiotics

NCT06702449Phase 1RecruitingPrimary

A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

NCT06976125Not ApplicableRecruitingPrimary

Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting

NCT07507851Not ApplicableNot Yet RecruitingPrimary

Electroacupuncture for the Prevention of Recurrent Lower Urinary Tract Infection in Women

NCT07501065Phase 4Not Yet RecruitingPrimary

Prophylactic Antibiotics for Outpatient Urethral Bulking

NCT05488340Phase 2RecruitingPrimary

A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)

NCT07438184Not ApplicableCompleted

Periodontal Therapy and Genitourinary Inflammation in Patients With Prostatitis and Recurrent Urinary Tract Infections

NCT05138822Phase 1Completed

Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections

NCT06808451Not ApplicableRecruitingPrimary

Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture

NCT05551949Phase 4Completed

Preventing Recurrent UTI With Vaginal Estrogen

NCT06715306Not ApplicableRecruiting

Intravenous Versus Oral Treatment of the Main Acute Infections

NCT05227937RecruitingPrimary

Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study

NCT04709601Phase 4TerminatedPrimary

Efficacy and Mechanism of Action of Methenamine Hippurate (Hiprex™) in Women With Recurring Urinary Tract Infections.

NCT05274672Phase 4Withdrawn

Role of Prophylactic Postoperative Antibiotics in HoLEP

NCT06597344Phase 3CompletedPrimary

A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)

NCT06710899Early Phase 1Not Yet RecruitingPrimary

Vitamin C and Hiprex in rUTI

Scroll to load more

Research Network

Activity Timeline